These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9012538)

  • 1. Improvement of glucose tolerance with immunomodulators on type 2 diabetic animals.
    Zhu XP; Satoh J; Muto G; Muto Y; Sagara M; Takahashi K; Seino H; Hirai S; Masuda T; Tanaka S; Ishida H; Seino Y; Toyota T
    Biotherapy; 1996; 9(4):189-97. PubMed ID: 9012538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone marrow transplantation as a strategy for treatment of non-insulin-dependent diabetes mellitus in KK-Ay mice.
    Than S; Ishida H; Inaba M; Fukuba Y; Seino Y; Adachi M; Imura H; Ikehara S
    J Exp Med; 1992 Oct; 176(4):1233-8. PubMed ID: 1402665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Docosahexanoic acid (DHA) improved glucose and lipid metabolism in KK-Ay mice with genetic non-insulin-dependent diabetes mellitus (NIDDM).
    Shimura T; Miura T; Usami M; Ishihara E; Tanigawa K; Ishida H; Seino Y
    Biol Pharm Bull; 1997 May; 20(5):507-10. PubMed ID: 9178930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidiabetic effects of corosolic acid in KK-Ay diabetic mice.
    Miura T; Ueda N; Yamada K; Fukushima M; Ishida T; Kaneko T; Matsuyama F; Seino Y
    Biol Pharm Bull; 2006 Mar; 29(3):585-7. PubMed ID: 16508174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study of effect of Humifuse Euphorbia Herb on alleviating insulin resistance in type 2 diabetic model KK-Ay mice].
    Wang LL; Fu H; Li WW; Song FJ; Song YX; Yu Q; Liu GX; Wang XM
    Zhongguo Zhong Yao Za Zhi; 2015 May; 40(10):1994-8. PubMed ID: 26390662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Actions of the novel oral antidiabetic agent HQL-975 in insulin-resistant non-insulin-dependent diabetes mellitus model animals.
    Ishikawa Y; Saito MN; Ikemoto T; Takeno H; Watanabe K; Tani T
    Diabetes Res Clin Pract; 1998 Aug; 41(2):101-11. PubMed ID: 9789716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antidiabetic effect of Nitobegiku, the herb Tithonia diversifolia, in KK-Ay diabetic mice.
    Miura T; Nosaka K; Ishii H; Ishida T
    Biol Pharm Bull; 2005 Nov; 28(11):2152-4. PubMed ID: 16272709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antidiabetic activity of perylenequinonoid-rich extract from Shiraia bambusicola in KK-Ay mice with spontaneous type 2 diabetes mellitus.
    Huang M; Zhao P; Xiong M; Zhou Q; Zheng S; Ma X; Xu C; Yang J; Yang X; Zhang TC
    J Ethnopharmacol; 2016 Sep; 191():71-81. PubMed ID: 27286915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The anti-diabetic activity of Bifidobacterium lactis HY8101 in vitro and in vivo.
    Kim SH; Huh CS; Choi ID; Jeong JW; Ku HK; Ra JH; Kim TY; Kim GB; Sim JH; Ahn YT
    J Appl Microbiol; 2014 Sep; 117(3):834-45. PubMed ID: 24925305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liraglutide ameliorates glycometabolism and insulin resistance through the upregulation of GLUT4 in diabetic KKAy mice.
    Chen LN; Lyu J; Yang XF; Ji WJ; Yuan BX; Chen MX; Ma X; Wang B
    Int J Mol Med; 2013 Oct; 32(4):892-900. PubMed ID: 23877319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-diabetic effects of globin digest and its active ingredient Leu-Ser-Glu-Leu in ICR mice, streptozotocin-induced diabetic mice and KK-Ay mice.
    Nakaoka F; Sasakawa Y; Yamamoto K; Nakao M; Nakamura M; Tong C; Fukuhama C; Kagawa K
    Life Sci; 2010 Mar; 86(11-12):424-34. PubMed ID: 20109472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoglycemic activity of to-kai-san (Chinese medicines) in normal and KK-Ay mice.
    Miura T; Noda M; Fukunaga T; Furuta K
    J Nutr Sci Vitaminol (Tokyo); 1997 Feb; 43(1):11-7. PubMed ID: 9151237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skeletal myoblast transplantation for attenuation of hyperglycaemia, hyperinsulinaemia and glucose intolerance in a mouse model of type 2 diabetes mellitus.
    Ye L; Lee KO; Su LP; Toh WC; Haider HK; Law PK; Zhang W; Chan SP; Sim EK
    Diabetologia; 2009 Sep; 52(9):1925-34. PubMed ID: 19593542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of long-term treatment with complete Freund's adjuvant on KK-Ay mouse, a model of non-insulin-dependent diabetes mellitus.
    Muto Y; Satoh J; Muto G; Masuda T; Sagara M; Fukuzawa M; Miyaguchi S; Qiang XL; Sakata Y; Nakazawa T; Ikehata F; Toyota T
    Clin Immunol Immunopathol; 1997 Apr; 83(1):53-9. PubMed ID: 9073536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of interleukin 17 in angiotensin II type 1 receptor-mediated insulin resistance.
    Ohshima K; Mogi M; Jing F; Iwanami J; Tsukuda K; Min LJ; Higaki J; Horiuchi M
    Hypertension; 2012 Feb; 59(2):493-9. PubMed ID: 22184328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unchanged gene expression of glycogen synthase in muscle from patients with NIDDM following sulphonylurea-induced improvement of glycaemic control.
    Vestergaard H; Lund S; Bjørbaek C; Pedersen O
    Diabetologia; 1995 Oct; 38(10):1230-8. PubMed ID: 8690177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetic bladder dysfunction in T2D KK-Ay mice and its changes in the level of relevant gene expression.
    Zhang J; Zhang Y; Yang X; Wang J; Xu Y; Wang R; Tan B; Huang P; Cao H
    Biomed Pharmacother; 2020 Nov; 131():110706. PubMed ID: 33152907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of beta-cell function after long-term treatment with either insulin, insulin plus gliclazide or gliclazide in neonatal streptozotocin-induced non-insulin-dependent diabetic rats.
    Kawai K; Suzuki S; Murayama Y; Watanabe Y; Yamashita K
    Diabetes Res Clin Pract; 1991 Jul; 12(3):163-72. PubMed ID: 1832376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin response to oral glucose load is consistently decreased in established non-insulin-dependent diabetes mellitus: the usefulness of decreased early insulin response as a predictor of non-insulin-dependent diabetes mellitus.
    Kosaka K; Kuzuya T; Hagura R; Yoshinaga H
    Diabet Med; 1996 Sep; 13(9 Suppl 6):S109-19. PubMed ID: 8894494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Actions of novel antidiabetic thiazolidinedione, T-174, in animal models of non-insulin-dependent diabetes mellitus (NIDDM) and in cultured muscle cells.
    Arakawa K; Ishihara T; Aoto M; Inamasu M; Saito A; Ikezawa K
    Br J Pharmacol; 1998 Oct; 125(3):429-36. PubMed ID: 9806323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.